Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | CPA1 | P15085 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4753641 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL23260544 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL584508 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL4753811 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL250457 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL288609 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL43380 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL18560091 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL2034664 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL43381 | 0.81 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661938-B1 | NOVEL METHOD FOR SYNTHESIZING AMANITINS | HEIDELBERG PHARMA RES GMBH (DE) | 2025-01-15 | — | — | EP | claimed |
| CN-118360279-A | Polynucleotide having lysE gene promoter activity and application thereof | 中国科学院天津工业生物技术研究所 | 2024-07-19 | — | — | CN | claimed |
| US-20230332116-A1 | POLYPEPTIDE WITH ASPARTATE KINASE ACTIVITY AND USE THEREOF IN PRODUCTION OF AMINO ACID | TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2023-10-19 | — | — | US | claimed |
| EP-4230723-A1 | POLYPEPTIDE WITH ASPARTATE KINASE ACTIVITY AND USE THEREOF IN PRODUCTION OF AMINO ACID | Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CN) | 2023-08-23 | — | — | EP | claimed |
| CN-109988312-B | Polyamide acid ester, preparation method, negative polyimide composition and application | 深圳先进技术研究院 | 2023-04-11 | — | — | CN | claimed |
| CN-115715294-A | Method for synthesizing thioether-containing peptides | 海德堡医药研究有限责任公司 | 2023-02-24 | — | — | CN | claimed |
| CN-112481186-B | Genetic engineering bacterium for producing 4-hydroxyisoleucine and application thereof | 天津科技大学 | 2023-02-03 | — | — | CN | claimed |
| CN-113201514-B | Polypeptides having aspartokinase activity and their use for producing amino acids | 中国科学院天津工业生物技术研究所 | 2022-09-06 | — | — | CN | claimed |
| CN-113201514-A | Polypeptides having aspartokinase activity and their use for producing amino acids | 中国科学院天津工业生物技术研究所 | 2021-08-03 | — | — | CN | claimed |
| CN-107149567-B | Plant mosquito-repellent spray for infants and preparation process thereof | 虞琼斐 | 2021-01-12 | — | — | CN | claimed |
| US-20060014159-A1 | Methods of determining precise HERG interactions and designing compounds based on said interactions | NEURION PHARMACEUTICALS, INC. (US) | 2006-01-19 | — | — | US | claimed |
| US-20050202103-A1 | Pregnane Glycoside compositions and caralluma extract products and uses thereof | RAJENDRAN RAMASWAMY (IN) | 2005-09-15 | — | — | US | claimed |
| WO-2004100968-A2 | A SYNERGISTIC COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS | INDUS BIOTECH PVT. LTD. (IN) | 2004-11-25 | — | — | WO | claimed |
| WO-2004034986-A2 | AGGLOMERATED GRANULAR PROTEIN-RICH NUTRITIONAL SUPPLEMENT | BASIC RESEARCH, L.L.C. (US) | 2004-04-29 | — | — | WO | claimed |
| CN-1065538-C | Antibiotic stalobacins | SHIONOGI & CO (JP) | 2001-05-09 | — | — | CN | claimed |
| US-6103231-A | Antibiotic stalobacins | SHIONOGI & CO., LTD. (JP) | 2000-08-15 | — | — | US | claimed |
| CN-1142230-A | Antibiotic stalobacins | SHIONOGI & CO (JP) | 1997-02-05 | — | — | CN | claimed |
| EP-0748335-A1 | ANTIBIOTIC STALOBACINS | SHIONOGI & CO., LTD. (JP) | 1996-12-18 | — | — | EP | claimed |
| US-5456910-A | Peptide antibiotics useful against grampositive bacteria | SHIONOGI & CO., LTD. (JP) | 1995-10-10 | — | — | US | claimed |
| WO-1995023812-A1 | ANTIBIOTIC STALOBACINS | SHIONOGI & CO., LTD. (JP) | 1995-09-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014159-A1 | Methods of determining precise HERG interactions and designing compounds based on said interactions | KCNN4, KCNC1, HCN4 | ALDH1A1 3649/4885L3MBTL1 219/4885FPR2 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.